Caspofungin - direct healthcare professional communication (DHPC)

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Caspofungin: Avoid use of polyacrylonitrile membranes during continuous renal replacement therapy

Key facts

• Active substance:
  caspofungin
• Regulatory outcome:
  Variation
• DHPC type:
  Post-authorisation measure
• Dissemination date:
  09/10/2025